started · updated
Bayer Crop Science targets €3B cash flow and sales growth by 2029
Bayer Crop Science has reaffirmed its five-year strategic framework, targeting significant financial and operational milestones by 2029. The division aims to achieve more than €3 billion in free operating cash flow, a mid-20s percentage EBITDA margin, and incremental sales of €3.5 billion. To support these goals, the company is focusing on innovation-led growth and margin improvements, including a target of over €1 billion in margin enhancements.
Product launches are central to this strategy. Bayer has already introduced a new insecticide in Colombia and plans to launch a low-growing maize cultivation system in Argentina this year. Upcoming releases include new soybean seeds in the United States and Canada, as well as a new soybean variety for Brazil in the 2027/2028 season. The company anticipates that these new soybean products alone could generate annual peak sales exceeding €3 billion.
On the operational side, Bayer has made progress in cost management and capital efficiency. The company reported reducing inventory by €500 million in 2025 and has achieved approximately €380 million in annualized run-rate margin benefits. Additionally, the division is working toward releasing approximately €1 billion in working capital by the end of 2026.
Entities
Bayer · Bayer Crop Science · Guru Ramamurthy · JPMorgan · Rodrigo Santos
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] The company targets more than €1 billion in margin improvements by 2029. www.marketbeat.com · www.cash.ch
- [○ 1 SOURCE] A new insecticide has been launched in Colombia. www.cash.ch
- [● 2 SOURCES] Bayer Crop Science targets more than €3 billion in free operating cash flow by 2029. www.marketbeat.com · www.cash.ch
- [○ 1 SOURCE] New soybean products are expected to generate annual peak sales exceeding €3 billion. www.cash.ch
- [● 2 SOURCES] Bayer reduced its inventory by €500 million in 2025. www.marketbeat.com · www.cash.ch
- [○ 1 SOURCE] Bayer targets more than €1.5 billion in cumulative working-capital cash release between 2024 and 2029. www.marketbeat.com
- [○ 1 SOURCE] A low-growing maize cultivation system is set to launch in Argentina this year. www.cash.ch
- [● 2 SOURCES] The division aims for €3.5 billion in incremental sales between 2024 and 2029. www.marketbeat.com · www.cash.ch